Article Details

Enzychem Lifesciences Announces Completion of Clinical Study Report (CSR) for Phase 2 ...

Retrieved on: 2022-03-10 02:50:18

Tags for this article:

Click the tags to see associated articles and topics

Enzychem Lifesciences Announces Completion of Clinical Study Report (CSR) for Phase 2 .... View article details on hiswai:

Excerpt

Enzychem Lifesciences (KOSDAQ: 183490), a late-stage biotechnology company, announced today that the company has completed the final Clinical ...

Article found on: www.bakersfield.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up